Re: Interim (18)F-Fluorodeoxyglucose Positron Emission Tomography for Early Metabolic Assessment of Response to Cisplatin, Etoposide, and Bleomycin Chemotherapy for Metastatic Seminoma: Clinical Value and Future Directions.
Richie, Jerome P
Re: Interim (18)F-Fluorodeoxyglucose Positron Emission Tomography for Early Metabolic Assessment of Response to Cisplatin, Etoposide, and Bleomycin Chemotherapy for Metastatic Seminoma: Clinical Value and Future Directions. [electronic resource] - The Journal of urology 07 2017 - 106 p. digital
Publication Type: Journal Article; Comment
1527-3792
10.1016/j.juro.2017.04.010 doi
Bleomycin
Cisplatin
Etoposide
Humans
Male
Positron-Emission Tomography
Seminoma
Testicular Neoplasms
Re: Interim (18)F-Fluorodeoxyglucose Positron Emission Tomography for Early Metabolic Assessment of Response to Cisplatin, Etoposide, and Bleomycin Chemotherapy for Metastatic Seminoma: Clinical Value and Future Directions. [electronic resource] - The Journal of urology 07 2017 - 106 p. digital
Publication Type: Journal Article; Comment
1527-3792
10.1016/j.juro.2017.04.010 doi
Bleomycin
Cisplatin
Etoposide
Humans
Male
Positron-Emission Tomography
Seminoma
Testicular Neoplasms